drugset / Trial / NCT06193174
Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine how safe and how well-tolerated the experimental study drug, C134 is when re-administered into the brain where the tumor is located.
Timeline
- Start
- 2024-06-21
- Primary completion
- 2025-03-07
- Completion
- 2025-03-07
Outcome
Outcome not reported
Stopped (Enrollment): “Not enough eligible participants to enroll.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C134 | Unknown | — | Other |